1. Academic Validation
  2. 2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 receptor antagonists

2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 receptor antagonists

  • Bioorg Med Chem Lett. 2014 Jun 1;24(11):2481-5. doi: 10.1016/j.bmcl.2014.04.011.
Carol H Hu 1 Jennifer X Qiao 2 Ying Han 3 Tammy C Wang 3 Ji Hua 3 Laura A Price 3 Qimin Wu 3 Hong Shen 3 Christine S Huang 3 Robert Rehfuss 3 Ruth R Wexler 3 Patrick Y S Lam 3
Affiliations

Affiliations

  • 1 Medicinal Chemistry, Molecular Sciences and Candidate Optimization, Bristol-Myers Squibb, 311 Pennington-Rocky Hill Road, Pennington, NJ 08534, USA. Electronic address: carol.hu@bms.com.
  • 2 Medicinal Chemistry, Molecular Sciences and Candidate Optimization, Bristol-Myers Squibb, 311 Pennington-Rocky Hill Road, Pennington, NJ 08534, USA. Electronic address: jennifer.qiao@bms.com.
  • 3 Medicinal Chemistry, Molecular Sciences and Candidate Optimization, Bristol-Myers Squibb, 311 Pennington-Rocky Hill Road, Pennington, NJ 08534, USA.
Abstract

Blockade of the P2Y1 Receptor is important to the treatment of thrombosis with potentially improved safety margins compared with P2Y12 Receptor antagonists. Investigation of a series of urea surrogates of the diaryl urea lead 3 led to the discovery of 2-amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 Receptor antagonists, among which compound 5a was the most potent and the first non-urea analog with platelet aggregation (PA) IC50 less than 0.5 μM with 10 μM ADP. Several 2-amino-1,3,4-thiadiazole analogs such as 5b and 5f had a more favorable pharmacokinetic profile, such as higher Ctrough, lower Cl, smaller Vdss, and similar bioavailability compared with 3.

Keywords

2-Amino-1,3,4-thiadiazoles; Antiplatelet; P2Y(1) receptor antagonist; Structure–activity relationship (SAR); Urea mimetics.

Figures